Literature DB >> 3128264

Peptide substrates for chymosin (rennin). Interaction sites in kappa-casein-related sequences located outside the (103-108)-hexapeptide region that fits into the enzyme's active-site cleft.

S Visser1, C J Slangen, P J van Rooijen.   

Abstract

The role of individual amino acid residues in the 98-102 and 111-112 regions of bovine kappa-casein in its interaction with the milk-clotting enzyme chymosin (rennin) was investigated. to this end the tryptic 98-112 fragment of kappa-casein was modified in its N- and/or C-terminal part by chemical (guanidation, ethoxyformylation, repeated Edman degradation) and enzymic (carboxypeptidase) treatments. Further, use was made of short synthetic kappa-casein analogues in which His-102 had been replaced by Pro or Lys. All peptides and their derivatives were tested comparatively at various pH values for their ability to act as chymosin substrates via specific cleavage of the peptide bond at position 105-106. The results indicate that in the alternating 98-102 sequence (His-Pro-His-Pro-His) the His as well as the Pro residues contribute to the substrate activity with no predominant role of any one of these groups. Another interaction site is formed by the Lys residue at position 111 of the substrate. A model of the enzyme-substrate complex is proposed. Herein the 103-108 fragment of the substrate, to be accommodated within the enzyme's active-site cleft, is brought into position by electrostatic binding (via His-98, His-100, His-102 and Lys-111) near the entrance of the cleft. These interactions are strongly supported by Pro residues at positions 99, 101, 109 and 110 of the substrate, which act as stabilizers of the proper conformation of the substrate in the enzyme-substrate complex.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3128264      PMCID: PMC1148031          DOI: 10.1042/bj2440553

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

1.  A general procedure for the manual sequencing of small quantities of peptides.

Authors:  G E Tarr
Journal:  Anal Biochem       Date:  1975-02       Impact factor: 3.365

2.  Modification of histidyl residues in proteins by diethylpyrocarbonate.

Authors:  E W Miles
Journal:  Methods Enzymol       Date:  1977       Impact factor: 1.600

3.  Studies on the specificity of chymosin (rennin). I. Kinetic parameters of the hydrolysis of synthetic oligopeptide substrates.

Authors:  M N Raymond; J Garnier; E Bricas
Journal:  Biochimie       Date:  1972       Impact factor: 4.079

4.  Segmented flow analysis as applied to kinetic studies of peptide bond hydrolysis.

Authors:  H J Vreeman; P J van Rooijen; S Visser
Journal:  Anal Biochem       Date:  1977-01       Impact factor: 3.365

5.  Peptide substrates for chymosin (rennin). Isolation and substrate behaviour of two tryptic fragments of bovine kappa casein.

Authors:  S Visser; P J Van Rooijen; C J Slangen
Journal:  Eur J Biochem       Date:  1980-07

6.  The involvement of one of the three histidine residues of cow kappa-casein in the chymosin-initiated milk clotting process.

Authors:  N M Kaye; P Jollès
Journal:  Biochim Biophys Acta       Date:  1978-10-23

7.  Modification of lactate oxidase with diethyl pyrocarbonate. Evidence for an active-site histidine residue.

Authors:  C Y Soon; M G Shepherd; P A Sullivan
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

8.  The irreversible cleavage of histidine residues by diethylpyrocarbonate (ethoxyformic anhydride).

Authors:  M J Loosemore; R F Pratt
Journal:  FEBS Lett       Date:  1976-12-15       Impact factor: 4.124

9.  Peptide substrates for chymosin (rennin). Kinetic studies with bovine kappa-casein-(103-108)-hexapeptide analogues.

Authors:  S Visser; P J Van Rooijen; C Schattenkerk; K E Kerling
Journal:  Biochim Biophys Acta       Date:  1977-03-15

10.  Ionic properties of an essential histidine residue in pig heart lactate dehydrogenase.

Authors:  J J Holbrook; V A Ingram
Journal:  Biochem J       Date:  1973-04       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.